145 related articles for article (PubMed ID: 17020880)
41. Biochemical and Structural Studies of the Interaction between ARAP1 and CIN85.
Li Q; Yang W; Wang Y; Liu W
Biochemistry; 2018 Apr; 57(14):2132-2139. PubMed ID: 29589748
[TBL] [Abstract][Full Text] [Related]
42. Promiscuous binding nature of SH3 domains to their target proteins.
Agrawal V; Kishan KV
Protein Pept Lett; 2002 Jun; 9(3):185-93. PubMed ID: 12144515
[TBL] [Abstract][Full Text] [Related]
43. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
Liu J; Li M; Ran X; Fan JS; Song J
Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
[TBL] [Abstract][Full Text] [Related]
44. CFBP is a novel tyrosine-phosphorylated protein that might function as a regulator of CIN85/CD2AP.
Konishi H; Tashiro K; Murata Y; Nabeshi H; Yamauchi E; Taniguchi H
J Biol Chem; 2006 Sep; 281(39):28919-31. PubMed ID: 16895919
[TBL] [Abstract][Full Text] [Related]
45. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.
Feng S; Chen JK; Yu H; Simon JA; Schreiber SL
Science; 1994 Nov; 266(5188):1241-7. PubMed ID: 7526465
[TBL] [Abstract][Full Text] [Related]
46. Rac1 recruits the adapter protein CMS/CD2AP to cell-cell contacts.
van Duijn TJ; Anthony EC; Hensbergen PJ; Deelder AM; Hordijk PL
J Biol Chem; 2010 Jun; 285(26):20137-46. PubMed ID: 20404345
[TBL] [Abstract][Full Text] [Related]
47. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions.
Simon JA; Schreiber SL
Chem Biol; 1995 Jan; 2(1):53-60. PubMed ID: 9383403
[TBL] [Abstract][Full Text] [Related]
48. The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals.
Cowan CA; Henkemeyer M
Nature; 2001 Sep; 413(6852):174-9. PubMed ID: 11557983
[TBL] [Abstract][Full Text] [Related]
49. Kinetics of Src homology 3 domain association with the proline-rich domain of dynamins: specificity, occlusion, and the effects of phosphorylation.
Solomaha E; Szeto FL; Yousef MA; Palfrey HC
J Biol Chem; 2005 Jun; 280(24):23147-56. PubMed ID: 15834155
[TBL] [Abstract][Full Text] [Related]
50. Mona/Gads SH3C binding to hematopoietic progenitor kinase 1 (HPK1) combines an atypical SH3 binding motif, R/KXXK, with a classical PXXP motif embedded in a polyproline type II (PPII) helix.
Lewitzky M; Harkiolaki M; Domart MC; Jones EY; Feller SM
J Biol Chem; 2004 Jul; 279(27):28724-32. PubMed ID: 15100220
[TBL] [Abstract][Full Text] [Related]
51. Structural insight into modest binding of a non-PXXP ligand to the signal transducing adaptor molecule-2 Src homology 3 domain.
Kaneko T; Kumasaka T; Ganbe T; Sato T; Miyazawa K; Kitamura N; Tanaka N
J Biol Chem; 2003 Nov; 278(48):48162-8. PubMed ID: 13129930
[TBL] [Abstract][Full Text] [Related]
52. CMS: an adapter molecule involved in cytoskeletal rearrangements.
Kirsch KH; Georgescu MM; Ishimaru S; Hanafusa H
Proc Natl Acad Sci U S A; 1999 May; 96(11):6211-6. PubMed ID: 10339567
[TBL] [Abstract][Full Text] [Related]
53. Intersectin 1 forms a complex with adaptor protein Ruk/CIN85 in vivo independently of epidermal growth factor stimulation.
Nikolaienko O; Skrypkina I; Tsyba L; Fedyshyn Y; Morderer D; Buchman V; de la Luna S; Drobot L; Rynditch A
Cell Signal; 2009 May; 21(5):753-9. PubMed ID: 19166927
[TBL] [Abstract][Full Text] [Related]
54. Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins.
Hu J; Hubbard SR
J Biol Chem; 2005 May; 280(19):18943-9. PubMed ID: 15737992
[TBL] [Abstract][Full Text] [Related]
55. The crystal structure of the N-terminal SH3 domain of Grb2.
Guruprasad L; Dhanaraj V; Timm D; Blundell TL; Gout I; Waterfield MD
J Mol Biol; 1995 May; 248(4):856-66. PubMed ID: 7752246
[TBL] [Abstract][Full Text] [Related]
56. Recognition of non-canonical peptides by the yeast Fus1p SH3 domain: elucidation of a common mechanism for diverse SH3 domain specificities.
Kim J; Lee CD; Rath A; Davidson AR
J Mol Biol; 2008 Mar; 377(3):889-901. PubMed ID: 18280496
[TBL] [Abstract][Full Text] [Related]
57. Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking.
Nonis D; Schmidt MHH; van de Loo S; Eich F; Dikic I; Nowock J; Auburger G
Cell Signal; 2008 Oct; 20(10):1725-39. PubMed ID: 18602463
[TBL] [Abstract][Full Text] [Related]
58. Making ends meet: the importance of the N- and C-termini for the structure, stability, and function of the third SH3 domain of CIN85.
Philippe D; Ababou A; Yang X; Ghosh R; Daviter T; Ladbury JE; Pfuhl M
Biochemistry; 2011 May; 50(18):3649-59. PubMed ID: 21446695
[TBL] [Abstract][Full Text] [Related]
59. CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells.
Niiro H; Jabbarzadeh-Tabrizi S; Kikushige Y; Shima T; Noda K; Ota S; Tsuzuki H; Inoue Y; Arinobu Y; Iwasaki H; Shimoda S; Baba E; Tsukamoto H; Horiuchi T; Taniyama T; Akashi K
Blood; 2012 Mar; 119(10):2263-73. PubMed ID: 22262777
[TBL] [Abstract][Full Text] [Related]
60. Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex.
Schmidt MHH; Hoeller D; Yu J; Furnari FB; Cavenee WK; Dikic I; Bögler O
Mol Cell Biol; 2004 Oct; 24(20):8981-93. PubMed ID: 15456872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
